MYC and cancer: We concluded that MYCMI-6 was well tolerated by the normal human cells at a concentration that was highly toxic to MYC-dependent tumors cells, showing good discrimination between cancer cells and normal cells in response to MYCMI-6 resulting in a good therapeutic window for this compound.